TOKYO and CAMBRIDGE, Mass., July 25, 2018 (GLOBE NEWSWIRE) —
Read moreEisai and Biogen Present Detailed Results From Phase II Clinical Study of Elenbecestat in MCI and Mild to Moderate Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2018
